Lanas Fernando, Garcia Maria Soledad, Paccot Melanie, Peña Jimena, Torres Pamela, Beaney Thomas, Ster Anca Chis, Poulter Neil R, Xia Xin
Departamento de Medicina Interna,Facultad de Medicina, Universidad de La Frontera, M Mont 112, Temuco 4780000, Chile.
Cardiovascular Diseases Program, Supervisor Physician, Servicio de Salud Araucanía Sur, Arturo Prat 969, Temuco 4780000, Chile.
Eur Heart J Suppl. 2020 Aug;22(Suppl H):H37-H39. doi: 10.1093/eurheartj/suaa023. Epub 2020 Aug 28.
Hypertension is highly prevalent in Chile. The National Health Survey 2016-17 reported a 27.6% prevalence, 68.7% awareness, and 33.3% of hypertensives had controlled blood pressure (BP). May Measurement Month (MMM) is a global initiative aimed at raising awareness of high BP and to act as a temporary solution to the lack of screening programmes worldwide. A cross-sectional survey of volunteers aged ≥18 years old was carried out in May 2018. Blood pressure measurement, the definition of hypertension, and statistical analysis followed the MMM protocol. Ninety-four sites participated, most of them from the Public Health System outpatient clinics distributed along the country. In addition, universities, clinical research sites, and private clinics participated. Hypertension was diagnosed as mean systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg or receiving antihypertensive medication. Overall 9344 individuals were screened. After multiple imputation, hypertension prevalence was 29.2%, of which 64.0% were aware of their condition. Of those aware of their hypertension diagnosis, 87.7% were receiving antihypertensive medication and 56.1% of the total number of hypertensives were on antihypertensive medication. Moreover, 15.3% of the participants who were not receiving treatment were considered potential hypertensives identified in the MMM18. MMM18 was one of the largest BP screening campaigns performed in Chile. It demonstrated a high prevalence of hypertension with one-third of these individuals having controlled BP. The high percentage of persons untreated or with uncontrolled hypertension while on pharmacologic treatment suggests that systematic screening programmes may be a useful tool to improve hypertension control in Chile.
高血压在智利极为普遍。2016 - 2017年全国健康调查显示，高血压患病率为27.6%，知晓率为68.7%，且33.3%的高血压患者血压得到控制。“五月测量月”（MMM）是一项全球倡议，旨在提高对高血压的认识，并作为全球筛查项目不足的临时解决方案。2018年5月对18岁及以上的志愿者进行了横断面调查。血压测量、高血压的定义及统计分析均遵循MMM方案。共有94个地点参与，其中大部分来自分布于全国各地的公共卫生系统门诊诊所。此外，还有大学、临床研究地点及私人诊所参与。高血压的诊断标准为平均收缩压≥140 mmHg和/或舒张压≥90 mmHg，或正在接受降压药物治疗。总共筛查了9344人。经过多重填补后，高血压患病率为29.2%，其中64.0%知晓自己的病情。在知晓自己患有高血压的人群中，87.7%正在接受降压药物治疗，高血压患者总数中有56.1%正在服用降压药物。此外，在未接受治疗的参与者中，15.3%被认为是在MMM18中识别出的潜在高血压患者。MMM18是智利开展的最大规模的血压筛查活动之一。它显示出高血压患病率很高，其中三分之一的患者血压得到控制。未接受治疗或在药物治疗时血压未得到控制的人群比例很高，这表明系统的筛查项目可能是改善智利高血压控制情况的有用工具。
